Burton Daniel D.
Officer at HCAT
- Sold, on record
- $49.8M
- Dollars the filings state
- Form 4 sales
- 13
- Latest Dec 7, 2021
- Form 144 notices
- 6
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- HCATHealth Catalyst, Inc.Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale HCATPlan not statedDec 6 2021
Sold 58,184 shares at $40.41 ($2.4M)
Burton Daniel D., Chief Executive Officer
Sold 19.7% of holdings ($11.9M position)236,906 shares left0.5x usual sizeFiling
- 2 Form 4 sale HCATPlan not statedDec 7 +1 day
Sold 15,530 shares at $40.47 ($628k)
Burton Daniel D., Chief Executive Officer
Sold 6.2% of holdings ($10.2M position)236,906 shares left0.1x usual sizeFiling
- 3 Form 144 notice HCATNoticeJun 1 +541 days
Filed to sell 7,411 shares ($83k)
Burton Daniel D., Officer
No 10b5-1 plan0.1x usual sizeFiling
- 4 Form 144 notice HCATNoticeSep 1 +92 days
Filed to sell 7,103 shares ($84k)
Burton Daniel D., Officer
No 10b5-1 plan0.1x usual sizeFiling
- 5 Form 144 notice HCATNoticeDec 1 +91 days
Filed to sell 8,478 shares ($63k)
Burton Daniel D., Officer
No 10b5-1 planFiling
- 6 Form 144 notice HCATNoticeMar 1 +91 days
Filed to sell 4,973 shares ($40k)
Burton Daniel D., Officer
No 10b5-1 planFirst sale on recordFiling
- 7 Form 144 notice HCATNoticeJun 3 +94 days
Filed to sell 4,442 shares ($29k)
Burton Daniel D., Officer
No 10b5-1 planFirst sale on recordFiling
- 8 Form 144 notice HCATNoticeDec 2 +182 days
Filed to sell 30,987 shares ($278k)
Burton Daniel D., Officer
No 10b5-1 planFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (19)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Dec 2, 2024 | HCAT | Officer | Form 144 notice | 30,987 | $278k | Notice | SEC | |
| Jun 3, 2024 | HCAT | Officer | Form 144 notice | 4,442 | $29k | Notice | SEC | |
| Mar 1, 2024 | HCAT | Officer | Form 144 notice | 4,973 | $40k | Notice | SEC | |
| Dec 1, 2023 | HCAT | Officer | Form 144 notice | 8,478 | $63k | Notice | SEC | |
| Sep 1, 2023 | HCAT | Officer | Form 144 notice | 7,103 | $84k | Notice | SEC | |
| Jun 1, 2023 | HCAT | Officer | Form 144 notice | 7,411 | $83k | Notice | SEC | |
| Dec 7, 2021 | HCAT | Chief Executive Officer | Form 4 sale | 15,530 | $628k | 6.2% | Plan not stated | SEC |
| Dec 6, 2021 | HCAT | Chief Executive Officer | Form 4 sale | 58,184 | $2.4M | 19.7% | Plan not stated | SEC |
| Sep 7, 2021 | HCAT | Chief Executive Officer | Form 4 sale | 73,820 | $4M | 23.9% | Plan not stated | SEC |
| Jun 7, 2021 | HCAT | Chief Executive Officer | Form 4 sale | 62,984 | $3.5M | 19.8% | Plan not stated | SEC |
| Jun 4, 2021 | HCAT | Chief Executive Officer | Form 4 sale | 171,372 | $9.1M | 37.7% | Unusual | SEC |
| Mar 2, 2021 | HCAT | Chief Executive Officer | Form 4 sale | 1,429 | $68k | 0.5% | Plan not stated | SEC |
| Dec 2, 2020 | HCAT | Chief Executive Officer | Form 4 sale | 21,609 | $761k | 10.2% | Plan not stated | SEC |
| Aug 25, 2020 | HCAT | Chief Executive Officer | Form 4 sale | 121,052 | $3.7M | 43.5% | Unusual | SEC |
| Aug 21, 2020 | HCAT | Chief Executive Officer | Form 4 sale | 122,868 | $4M | 43.8% | Unusual | SEC |
| Aug 19, 2020 | HCAT | Chief Executive Officer | Form 4 sale | 149,687 | $4.9M | 48.7% | Unusual | SEC |
| Aug 17, 2020 | HCAT | Chief Executive Officer | Form 4 sale | 171,612 | $5.5M | 48.5% | Unusual | SEC |
| Jul 31, 2020 | HCAT | Chief Executive Officer | Form 4 sale | 200,570 | $7.1M | 52.4% | Unusual | SEC |
| Jun 26, 2020 | HCAT | Chief Executive Officer | Form 4 sale | 140,908 | $4.4M | 47.2% | Unusual | SEC |